SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-04-031002
Filing Date
2004-10-19
Accepted
2004-10-19 14:14:20
Documents
5
Period of Report
2004-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-11732_18k.htm 8-K 40620
2 EX-10.1 a04-11732_1ex10d1.htm EX-10.1 98003
3 EX-10.2 a04-11732_1ex10d2.htm EX-10.2 126530
4 EX-99.1 a04-11732_1ex99d1.htm EX-99.1 15398
5 GRAPHIC g117321mmimage002.jpg GRAPHIC 4025
  Complete submission text file 0001104659-04-031002.txt   286829
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 041084959
SIC: 2835 In Vitro & In Vivo Diagnostic Substances